Atrion: stocks, financial statements

Disable ads for free
Dividends News

Development and production of products, primarily for medical use. It ranges from fluid delivery devices (such as valves) to eye and cardiovascular devices.The company also produces specialized medical devices for contact lens disinfection. It also produces measuring devices and related supplies that measure blood clotting time; and a line of products designed to safely hold a needle and scalpel blade.

In addition, there is a separate production of inflatable systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; one-way and two-way pressure relief valves that protect sensitive electronics. The company's clients are: doctors, hospitals, clinics and other medical centers; as well as other equipment manufacturers. Trade is carried out through direct sales, independent sales representatives and distributors.

  • ATRI Ticker
  • NASDAQ Exchange
  • 570 Employees
2 rated
  • $594.41, +$3.81 (+0.65%) Previous Close
  • 10,897 Previous Volume
  • $576.60 / $751.68 52 week low / high
  • -20.92% Percent off 52 week high
  • 2020-11-27 Updated
  • 1.08% Dividend Yield (trailing)
  • 1.18% Dividend Yield (forward)
  • 0 Public float
  • 1,828,953 Outstanding shares
  • 33.13 P/E
  • 1.09 B Market Cap
Disable ads for free

Financial statements — Atrion

The information is not 100% up-to-date. There may be errors or missing information. Some information is often missing, and, although there are almost no errors, I can't rule them out. Right now, I'm looking for a supplier of high-quality information, but so far what I'm finding is expensive (about $2000 a year). You can help my project here.
19 ← 15 2019 2018 2017 2016 2015
Total Revenue
160M 150M 150M 140M 150M
Cost Of Revenue
84M 81M 76M 76M 75M
Gross Profit
71M 72M 71M 68M 71M
Research and Development
5.5M 5.8M 6.6M 6.3M
Selling General and Admin
25M 24M 22M 22M
Operating Expense
110M 110M 110M 100M 100M
Operating Income
41M 42M 41M 39M 43M
Other Income Expense Net
2.6M 330K 1.1M 140K -1.6M
41M 42M 41M 39M 43M
Interest Income
Pretax Income
43M 42M 42M 39M 41M
Income Tax
6.4M 7.8M 5.7M 12M 12M
Minority Interest
0 0 0 0 0
Net Income
37M 34M 37M 28M 29M
Net Income Basic
37M 34M 37M 28M 29M
19 ← 15 2019 2018 2017 2016 2015
Current cash
45M 59M 30M 20M 28M
Short term investments
24M 9.7M 35M 24M 44K
19M 17M 17M 17M 17M
42M 34M 29M 29M 30M
Other current assets
2.5M 3.2M 3.2M 3.8M 3.5M
Current assets
130M 120M 120M 94M 78M
Long term investments
32M 21M 9.1M 9.9M 9.9M
Property plant equipment
85M 75M 66M 65M 63M
9.7M 9.7M 9.7M 9.7M 9.7M
Intangible assets
1.5M 1.7M 1.8M 1.9M 2.2M
Other assets
2M 1.6M 1.5M 1.6M 940K
Total assets
260M 230M 200M 180M 160M
Accounts payable
5.7M 5.1M 3.9M 4M 3.9M
Current long term debt
Other current liabilities
5.1M 4.5M 4.9M 4.6M 5.1M
Total current liabilities
11M 10M 9.6M 9.1M 9.3M
Long term debt
Other liabilities
4.4M 3.5M 2.5M 1.1M 930K
Minority Interest
0 0 0 0 0
Total Liabilities
24M 20M 19M 20M 20M
Common stock
1.9M 1.9M 1.8M 1.8M 1.8M
Retained earning
320M 290M 270M 240M 220M
Treasury stock
430K 430K 430K 410K 430K
Capital surplus
52M 50M 49M 37M 36M
Shareholder equity
240M 210M 180M 160M 140M
Net tangible assets
200M 180M 150M 130M 110M
19 ← 15 2019 2018 2017 2016 2015
Net Income
37M 34M 37M 28M 29M
11M 9.1M 8.7M 9M 8.8M
Changes in receivables
-1.9M 62K 90K -550K
Changes in inventories
-8.5M -4.2M -340K 760K -1.7M
Cash change
-14M 29M 10M -8.3M 7.6M
Cash flow
42M 43M 47M 37M 40M
Capital expenditures
-20M -18M -9.7M -11M -9.3M
-24M 12M -11M -26M 13M
Investing activity other
Total investing cash flows
-45M -5.1M -21M -36M 3.9M
Dividends paid
-11M -9.4M -8.3M -7.1M -6.1M
Net borrowings
Other financing cash flows
-580K -90K -7.7M -1.1M 2K
Cash flow financing
-11M -9.5M -16M -9.5M -37M
Exchange rate effect
Disable ads for free